COVID-19: consider cytokine storm syndromes and immunosuppression
Puja MehtaCentre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UKDaniel F. McAuleyWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK; Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UKMichael BrownHospital for Tropical Diseases, University College London Hospital, London NW1 2PG, UKEmilie SanchezDepartment of Clinical Virology, University College London Hospital, London NW1 2PG, UKRachel TattersallDepartment of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UKJessica MansonDepartment of Rheumatology, University College London Hospital, London NW1 2PG, UK. Electronic address: [email protected]
2020en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
5 та иқтибос0 та фойдаланилган манба